Search

Zachariah Lucas

Supervisory Patent Examiner (ID: 15977, Phone: (571)272-0905 , Office: P/1600 )

Most Active Art Unit
1648
Art Unit(s)
1600, 1648
Total Applications
707
Issued Applications
248
Pending Applications
93
Abandoned Applications
367

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5040616 [patent_doc_number] => 20070092898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Detection of multiple anti-viral antibodies' [patent_app_type] => utility [patent_app_number] => 11/504510 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12380 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092898.pdf [firstpage_image] =>[orig_patent_app_number] => 11504510 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/504510
Detection of multiple anti-viral antibodies Aug 14, 2006 Abandoned
Array ( [id] => 5171744 [patent_doc_number] => 20070072176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/503245 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 35072 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072176.pdf [firstpage_image] =>[orig_patent_app_number] => 11503245 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/503245
Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus Aug 10, 2006 Abandoned
Array ( [id] => 5051420 [patent_doc_number] => 20070031965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Anti-pathogen treatments' [patent_app_type] => utility [patent_app_number] => 11/503416 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 93393 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031965.pdf [firstpage_image] =>[orig_patent_app_number] => 11503416 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/503416
Anti-pathogen treatments Aug 10, 2006 Issued
Array ( [id] => 285639 [patent_doc_number] => 07550566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'G-CSF conjugates' [patent_app_type] => utility [patent_app_number] => 11/463863 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37996 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550566.pdf [firstpage_image] =>[orig_patent_app_number] => 11463863 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/463863
G-CSF conjugates Aug 9, 2006 Issued
Array ( [id] => 285638 [patent_doc_number] => 07550565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'G-CSF conjugates' [patent_app_type] => utility [patent_app_number] => 11/463861 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37952 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550565.pdf [firstpage_image] =>[orig_patent_app_number] => 11463861 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/463861
G-CSF conjugates Aug 9, 2006 Issued
Array ( [id] => 5687754 [patent_doc_number] => 20060286069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'G-CSF Conjugates' [patent_app_type] => utility [patent_app_number] => 11/463867 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37966 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286069.pdf [firstpage_image] =>[orig_patent_app_number] => 11463867 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/463867
G-CSF conjugates Aug 9, 2006 Issued
Array ( [id] => 5609313 [patent_doc_number] => 20060270829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'G-CSF CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/462335 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35614 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270829.pdf [firstpage_image] =>[orig_patent_app_number] => 11462335 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/462335
G-CSF CONJUGATES Aug 2, 2006 Abandoned
Array ( [id] => 5142688 [patent_doc_number] => 20070004904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'G-CSF CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/462354 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35623 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004904.pdf [firstpage_image] =>[orig_patent_app_number] => 11462354 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/462354
G-CSF CONJUGATES Aug 2, 2006 Abandoned
Array ( [id] => 5080472 [patent_doc_number] => 20070123696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'G-CSF CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/462331 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35687 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123696.pdf [firstpage_image] =>[orig_patent_app_number] => 11462331 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/462331
G-CSF CONJUGATES Aug 2, 2006 Abandoned
Array ( [id] => 5296038 [patent_doc_number] => 20090010964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines' [patent_app_type] => utility [patent_app_number] => 11/794503 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11589 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010964.pdf [firstpage_image] =>[orig_patent_app_number] => 11794503 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/794503
Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines Aug 2, 2006 Abandoned
Array ( [id] => 5609187 [patent_doc_number] => 20060270703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'G-CSF CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/462353 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35608 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270703.pdf [firstpage_image] =>[orig_patent_app_number] => 11462353 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/462353
G-CSF CONJUGATES Aug 2, 2006 Abandoned
Array ( [id] => 5887521 [patent_doc_number] => 20060275257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'G-CSF Conjugates' [patent_app_type] => utility [patent_app_number] => 11/462037 [patent_app_country] => US [patent_app_date] => 2006-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31731 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275257.pdf [firstpage_image] =>[orig_patent_app_number] => 11462037 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/462037
G-CSF Conjugates Aug 1, 2006 Abandoned
Array ( [id] => 5661496 [patent_doc_number] => 20060252092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Pharmaceutical composition containing disrupted cell suspension of Monilia albicans and euglobulin and method of treating animals infected with canine distemper virus or animals having neurological disorders by using the same' [patent_app_type] => utility [patent_app_number] => 11/486885 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4605 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252092.pdf [firstpage_image] =>[orig_patent_app_number] => 11486885 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/486885
Pharmaceutical composition containing disrupted cell suspension of Monilia albicans and euglobulin and method of treating animals infected with canine distemper virus or animals having neurological disorders by using the same Jul 13, 2006 Issued
Array ( [id] => 5732248 [patent_doc_number] => 20060257365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection' [patent_app_type] => utility [patent_app_number] => 11/478879 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6232 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257365.pdf [firstpage_image] =>[orig_patent_app_number] => 11478879 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/478879
Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Jun 29, 2006 Abandoned
Array ( [id] => 5034757 [patent_doc_number] => 20070099296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs' [patent_app_type] => utility [patent_app_number] => 11/453578 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099296.pdf [firstpage_image] =>[orig_patent_app_number] => 11453578 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/453578
Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs Jun 13, 2006 Abandoned
Array ( [id] => 5625315 [patent_doc_number] => 20060263820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins' [patent_app_type] => utility [patent_app_number] => 11/449829 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7150 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263820.pdf [firstpage_image] =>[orig_patent_app_number] => 11449829 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/449829
Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins Jun 8, 2006 Issued
Array ( [id] => 5563663 [patent_doc_number] => 20090136515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Methods of diagnosing, preventing and treating infection with Hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/921285 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10811 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136515.pdf [firstpage_image] =>[orig_patent_app_number] => 11921285 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/921285
Methods of diagnosing, preventing and treating infection with Hepatitis C virus Jun 1, 2006 Abandoned
Array ( [id] => 5188015 [patent_doc_number] => 20070166323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Yeast-dendritic cell vaccines and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/446597 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20187 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166323.pdf [firstpage_image] =>[orig_patent_app_number] => 11446597 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/446597
Yeast-antigen compositions methods of making the same May 31, 2006 Issued
Array ( [id] => 4443897 [patent_doc_number] => 07862821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Recombinant vaccine against bluetongue virus' [patent_app_type] => utility [patent_app_number] => 11/444698 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 21 [patent_no_of_words] => 28352 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/862/07862821.pdf [firstpage_image] =>[orig_patent_app_number] => 11444698 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/444698
Recombinant vaccine against bluetongue virus May 31, 2006 Issued
Array ( [id] => 5890410 [patent_doc_number] => 20060276622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM' [patent_app_type] => utility [patent_app_number] => 11/419528 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 28660 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276622.pdf [firstpage_image] =>[orig_patent_app_number] => 11419528 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/419528
PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM May 21, 2006 Abandoned
Menu